MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Movement Disorders In Children With Monoamine Neurotransmitter Disorders

    M. Ben Hafsa, H. Benrhouma, T. Ben Younes, H. Klaa, A. Zioudi, Z. Miladi, I. Ben Youssef-Turki, I. Kraoua (Tunis, Tunisia)

    Objective: To describe clinical, para-clinical, therapeutic and evolutionary characteristics of movement disorders (MD) and oculogyric crises (OC) in children with monoamine neurotransmitter disorders (MND) Background:…
  • 2024 International Congress

    Parkinsonism in combined Fragile X and XYY Syndromes: A Case Report

    M. Carta, B. Balint (Zurich, Switzerland)

    Objective: We describe an unusual case of parkinsonism in a 45-year-old male with Fragile X syndrome and XYY syndrome. Background: Fragile X syndrome (FXS) is…
  • 2024 International Congress

    A Benign Course of Parkinson’s Disease Associated with Different Mutations in the Glucocerebrosidase (GBA) Gene – a Case Series.

    M. Cohen, Y. Schechter, R. Eichel, G. Yahalom (Jerusalem, Israel)

    Objective: To describe a subtype of GBA-associated Parkinson's disease with a benign motor and cognitive course of disease. Background: Subjects carrying mutations in the GBA…
  • 2024 International Congress

    Remote DNA Collection for Parkinson’s Research: Insights from AccessPD

    Y-H. Chang, E. Shelton, H. Chohan, M. Periñan, A. Noyce (London, United Kingdom)

    Objective: Established in 2022, the AccessPD registry aims to create a comprehensive database of electronic health records, self-reported outcomes, and genetic data from Parkinson's disease…
  • 2024 International Congress

    Unraveling the Role of Short Tandem Repeats in Parkinson’s disease, Essential tremor, and Amyotrophic lateral sclerosis: A Large Chinese Cohort Study

    Y. Zhao, Z. Liu, H. Pan, Q. Sun, J. Wang, J. Guo, B. Tang (Changsha, China)

    Objective: This study investigates the prevalence and impact of short tandem repeat (STR) mutations in the next-generation sequencing data of patients with Parkinson’s disease (PD), essential…
  • 2024 International Congress

    Bidirectional Relationship Between Olfaction and Parkinson’s Disease

    J. Kim, S. Bandres-Ciga, K. Heilbron, 23. INC., C. Blauwendraat, A. Noyce (London, United Kingdom)

    Objective: To establish a causal direction and genetic relationship between olfactory function and Parkinson’s disease (PD). Background: Degradation in olfactory function or hyposmia is a…
  • 2024 International Congress

    A UK-wide Effort for Identification of Loci for Autosomal Dominant Parkinson’s Disease

    R. Tilney, R. Real, S. Jasaityte, Z. Fang, M. Fenn, L. Lange, A. Singleton, C. Blauwendraat, C. Klein, H. Morris, GP2. Genetic Program (London, United Kingdom)

    Objective: (i) To describe the demographic, clinical and genetic features of a large cohort of familial autosomal dominant Parkinson’s disease (PD) patients in the UK.(ii)…
  • 2024 International Congress

    A new phenotype-genotype correlation for FIG4 gene and Parkinson’s disease

    I. Boura, G. Xiromerisiou, I A. Giannopoulou, P. Mitsias, C. Spanaki (HERAKLION, Greece)

    Objective: We present a patient with atypical Parkinson’s disease (PD), carrying a homozygous missense mutation of FIG4. Background: FIG4 is involved in endosomal-lysosomal trafficking and…
  • 2024 International Congress

    Transition from Zinc Salts to Trientine Tetrahydrochloride in Wilson Disease: Clinical and Biochemical Effects over Two Years – the ZICUP study

    A. Poujois, MA. Obadia, N. Oussedik-Djebrani, E. Couchonnal-Bedoya, F. Ory-Magne, D. Debray (France, France)

    Objective: To assess the clinical and biochemical effects of transitioning from zinc salts (ZS) to trientine tetrahydrochloride (TETA4HCL) in Wilson disease (WD) patients over a…
  • 2024 International Congress

    Dopa-responsive ataxia with compound heterozygous variants in MRE11

    A. Dugar, E. Levine, M. Barbosa, W. Tse (New York, USA)

    Objective: To evaluate the role for levodopa in patients with ataxia telangiectasia like disorder (ATLD) who have a compound heterozygous mutation in MRE11. Background: Early-onset…
  • « Previous Page
  • 1
  • …
  • 166
  • 167
  • 168
  • 169
  • 170
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #25116 (not found)
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley